Literature DB >> 6472495

Brain and serum concentrations of dopamine analogues after peripheral administration to rats.

M G Feenstra, J W Homan, R Everts, H Rollema, A S Horn.   

Abstract

Concentrations of dopamine (DA) analogues were determined in rat brain regions and serum after peripheral administration of the drugs. The time course of the concentrations of four N,N-dialkylated DA derivatives is reported in relation to the simultaneously measured effects on DA metabolism. Maximum brain concentrations were reached at about 10 min after injection, followed by a rapid elimination of the parent compounds. O-Methylation was found to be of major importance in this early disappearance. The 3-O-methyl metabolite of N,N-dipropyl-DA (DiPr-DA) was very rapidly formed and was eliminated much more slowly than the parent compound. Inhibition of O-methylation as well as subcutaneous, instead of intraperitoneal (ip), administration resulted in higher brain and serum levels of DiPr-DA. Brain concentrations of 11 DA analogues were determined 10 min after ip injection and were compared with their octanol/water (pH 7.4) partition coefficients. Within one group of compounds with a similar metabolic profile the brain concentrations and partition coefficients showed a good correlation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472495     DOI: 10.1007/bf00505319

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists.

Authors:  J D McDermed; G M McKenzie; A P Phillips
Journal:  J Med Chem       Date:  1975-04       Impact factor: 7.446

2.  Lipid solubility and drug penetration of the blood brain barrier.

Authors:  W H Oldendorf
Journal:  Proc Soc Exp Biol Med       Date:  1974-12

3.  Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats.

Authors:  S Lal; T L Sourkes; K Missala; G Belendiuk
Journal:  Eur J Pharmacol       Date:  1972-10       Impact factor: 4.432

4.  Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.

Authors:  R J Baldessarini; N S Kula; K G Walton
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

5.  Dissociation constants and lipophilicity of catecholamines and related compounds.

Authors:  F Mack; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

6.  Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum.

Authors:  M G Feenstra; H Rollema; A S Horn; D Dijkstra; C J Grol; B H Westerink; A Westerbrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-01       Impact factor: 3.000

7.  Rapid concurrent automated fluorimetric assay of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 3-methoxytyramine in milligram amounts of nervous tissue after isolation on Sephadex G10.

Authors:  B H Westerink; J Korf
Journal:  J Neurochem       Date:  1977-10       Impact factor: 5.372

8.  Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-performance liquid chromatography with a novel type of electrochemical detection.

Authors:  B H Westerink; T B Mulder
Journal:  J Neurochem       Date:  1981-04       Impact factor: 5.372

9.  Behavioral effects and cerebral pharmacokinetics of apomorphine in the rat: dependence upon the route of administration.

Authors:  M Melzacka; G Wiszniowska; W Daniel; J Vetulani
Journal:  Pol J Pharmacol Pharm       Date:  1979 Jul-Aug

10.  In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.

Authors:  M G Feenstra; H Rollema; T B Mulder; B H Westerink; A S Horn
Journal:  Life Sci       Date:  1983-03-21       Impact factor: 5.037

View more
  1 in total

1.  Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.

Authors:  T B Mulder; J B de Vries; D Dijkstra; J W Wiechers; C J Grol; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.